Special
The best period tracking apps of 2023
We’ve rounded up the best period trackers for 2023 to help you find the right one for you
In the age of technological advancements, period tracking apps have emerged as invaluable tools for women to monitor and manage their menstrual cycles.
With a range of features that allow women to log in their periods, track symptoms, identify patterns and gain a better understanding of their bodies, these apps have become increasingly popular and have revolutionised the way women approach their reproductive health.
But that’s not all they are good for. Research shows apps can also provide timely information about specific contraceptive methods, ovulation and fertility windows, making them great tools for family planning.
Trackers can also foster open conversations about menstruation and provide platforms for sharing experiences and insights within supportive communities, destigmatising discussions around menstruation and female health more generally.
However, most period tracking apps are not appropriate to prevent pregnancy, so do use them with caution, if you had that in mind.
But if you are keen to learn more about cycle tracking, map your periods, monitor your ovulation, or keep tabs on your reproductive health, try some of our top picks below.
Nexus isn’t just a cycle tracker, it’s a holistic women’s health coach which includes a cycle tracker but also nutrition, exercise and more to give you a more comprehensive experience when engaging with Nova, your AI coach
Nexus bridges this gap with a female-specific onboarding process offering over 50,000 unique combinations of personalised wellness insights.
With Nova, users also have access to an AI coach that truly knows them, offering adaptive, actionable guidance grounded in science and tailored to each woman’s unique physiology and life stage.
The vision behind Nexus is to give women control over their own health data, using it to improve conversations with healthcare providers, reduce medical gaslighting and accelerate diagnosis times through advocacy and education.
At the heart of Nexus lies a proprietary large language model (LLM) and peer-reviewed health database, built specifically for women. This architecture blends medical research, clinical guidelines and user data to generate precise recommendations, far surpassing the capabilities of off-the-shelf AI systems.
- Built by medical professionals and scientists. Our team of experts have built, reviewed and tested this product.
- AI-powered health coach Nova, built from scratch to handle the bias and hallucinations for women’s health with AI
- Personalized experience: Nexus adjusts predictions and recommendations to each user’s unique cycle and health characteristics.
- Nexus is free with no upsales or features behind the pay wall.
- 5* reviews in the App Store.
- Your data is private. We don’t share your personal data with the AI model or any 3rd parties.
Nexus is only available on the UK Apple app store currently. You can download the app here or join the international / Android waitlist here. Coming early 2026.
Clue is a Berlin-based reproductive health company that supports, educates and empowers women and people with cycles with personalized health insights to support them from their first period to their last.
Created with science and technology at its core, the company’s mission is to be a trusted companion, empowering people around the world on their journeys to self-discovery and reproductive health.
Founded in 2012, Clue was one of the first femtech companies, serves millions of people around the world in 190 countries, and regularly partners with universities, researchers and clinicians on research to help address health gaps.
Clue’s app is free to download and includes its signature Period Tracking feature, with additional personalised modes like Clue Conceive and others available in the premium subscription offering, Clue Plus.
For more, visit helloclue.com.
Premom offers personalised, science-backed insights to help you better understand your body—whether you’re just tracking your cycle or actively trying to conceive.
What makes Premom different? It’s designed by fertility experts and powered by smart technology.
When you log ovulation tests, basal body temperature (BBT), cervical mucus, and other symptoms, Premom’s AI algorithm learns from your unique patterns—even if your cycles are irregular.
You’ll get a clear, easy-to-read period and ovulation calendar, automatic hormone and BBT charting, and real-time predictions so you can confidently spot your fertile window.
Created by the makers of Easy@Home ovulation tests, it’s helped over 1 million users get pregnant while using Premom.
Need extra support?
- FastPass™ to Pregnancy gives you a step-by-step plan to conceive faster, with smarter ovulation predictions, weekly expert video tips, and personalized guidance.
- Fertility AI Pro helps you make sense of your hormone results and gives you instant, expert-backed answers so you’re never left guessing.
- Pregnancy Mode kicks in once you’re expecting—with weekly updates on your baby’s development, body changes, and tips to feel your best each trimester.
- Predad™ keeps your partner involved with updates and ideas to stay connected and supportive through it all.
Want to go deeper? Premom Premium unlocks advanced fertility reports, expert-led webinars, and tools like a PCOS self-assessment so you feel informed and empowered every step of the way.
The Premom app is free to download with the option to upgrade for further support.
Learn more at www.premom.com
*Over 1 million users logged pregnancy or positive pregnancy test results while using the Premom App
WomanLog
WomanLog is a reliable and easy-to-use period tracker app tailor-made for women of all ages in every moment of their health.
There are dozens of complex processes that take over a woman’s body every day. Why not be aware of them and be prepared for everything?
WomanLog, a free multi-use app, is much more than a digital calendar that tracks menstruation cycle, sex life and contraception used. It has an encyclopedia of more than 200 symptoms that may occur in a woman’s body during her cycle.
The Latvia-based start-up is among the leaders in the global market for more than 10 years. Translated into 30 languages, it has 1.5 million active monthly users worldwide and more than 20 million installs.
WomanLog app has three modes: period tracker, pregnancy and menopause mode. WomanLogBaby app helps to track every step of baby’s daily activities while “Intelligent Assistant” with cutting-edge Artificial Intelligence and Machine Learning technology offers even more detailed analysis.
Users are constantly introduced to articles on women’s health, psychology, daily life and activities.
Data safety in the key point of every app, and WomanLog is the leader with the highest security level that meets all the GDPR standards.
Moreover, the web version of WomanLog, available without even signing-in, features online calculators that count the days left until your next period or fertility windows within seconds.
For more, visit womanlog.com.
Wild.AI
Wild.AI has done extensive research on what a woman is, studying what the female body needs and when.
The company translates this research into the app, helping woman track, train, eat, and recover, with their physiology – whether they menstruate, use birth control, or are in perimenopause or menopause.
While all products, apps, and wearables seem to serve men well, Wild.AI interprets data through a female lens. The readiness score is calculated by the combination of wearable data and daily subjective check-ins, including symptoms, stress levels and periods.
As an example, if the body temperature goes up, as a man, it could mean you are sick. As a woman, it may mean you ovulate, you’re pregnant, or have perimenopausal symptoms.
Wild.AI provides daily adaptive and personalised recommendations that take the ever-changing daily context into account and adapts with you, effectively acting as human data-scientist, a coach, and a nutritionist.
The app is launching the coach interface alongside the coach academy, to upskill coaches and let them train women with their physiology seamlessly.
Led by Helene Guillaume and Dr Stacy Sims, this is possible thanks to the research conducted internally and in partnership with universities, continuously advancing the knowledge on female health, and covering more life stages over time, 50+ female-specific symptoms, 149 different birth controls – and counting.
In a one-stop-shop, Wild.AI is the performance platform for women, establishing itself as the gold standard in the industry.
For more, visit wild.ai.
Spot On
Spot On is Planned Parenthood’s free, medically accurate, period and birth control tracking app. The app — available in both English and Spanish — has over six birth control methods you can choose to track (the pill, patch, ring, shot, IUD, and implant) and over 180 brands represented that you can sync the app to.
It also offers advice tailored to you based on your unique cycle and schedule, birth control, and reproductive goals.
Since its launch in 2016, Spot On has had over 2.6 million downloads, and close to 73,000 monthly engaged users who log on and track their period, mood, activity and/or birth control.
Spot On offers an inclusive user experience, never making assumptions about your gender, sexual orientation, or reproductive goals. This app talks about your period and birth control the way real people do (so, no pink flowers or butterflies).
In a post-Roe world, Spot On is committed to data privacy, allowing users to choose to create an account or use the app anonymously.
Spot On’s usership over-indexes BiPOC representation in comparison to the US population: Spot On has 58 per cent BiPOC users as compared to 42 per cent of the US population.
The majority of Spot On users are between ages 18-24 (42 per cent), closely followed by ages 25-29 (24 per cent). Most of its engaged users are patients at Planned Parenthood health centres.
Spot On does not display ads or prompt users to upgrade. The app’s north star is to increase user engagement and satisfaction and to empower BiPOC community members to make informed decisions about their sexual and reproductive, mental, and physical health goals.
For more, visit plannedparenthood.org.
To receive the Femtech World newsletter, sign up here.
Former US first lady Dr Jill Biden visited Imperial College Healthcare NHS Trust and Imperial College London to explore work on women’s health and antimicrobial resistance.
The visit was hosted by professor the Lord Darzi of Denham, who chairs the Fleming Initiative and directs Imperial’s Institute of Global Health Innovation.
Dr Biden, chair of the Milken Institute’s Women’s Health Network, spoke about the impact scientists, clinicians, innovators and investors can have on improving women’s healthcare.
Dr Biden stressed the importance of “collaboration, prevention and education” in improving women’s health globally.
At the museum, Dr Biden and Esther Krofah, executive vice-president of health at the Milken Institute, heard about the worldwide significance of the discovery and the contribution of women who, during wartime Britain, grew penicillin in bedpans to support early experimentation.
The discussion also explored how AMR is a key women’s health issue, with women disproportionately affected in low and middle-income countries, and in high-income settings where women are more likely than men to be prescribed antibiotics.
Dr Biden was shown an architectural model of the Fleming Centre in Paddington, which will bring together research, policy and public engagement to address AMR worldwide.
The second part of the visit brought together Imperial clinicians, researchers and innovators for a roundtable on women’s health priorities, including improving diagnosis, equity in maternity care and support during the menopause transition.
Participants highlighted wide variation in the quality of care for conditions affecting women and called for fairer access to services, with the postcode lottery named as a priority to address.
Professor Tom Bourne, consultant gynaecologist and chair in gynaecology at Imperial’s Department of Metabolism, Digestion and Reproduction, described how AI could improve diagnostic accuracy for conditions such as endometriosis.
Equity emerged as a central theme.
Professor Alison Holmes, professor of infectious diseases at Imperial College London and director of the Fleming Initiative, highlighted persistent gaps in women’s representation in clinical trials, including antibiotic studies, which limits the ability to optimise care and treatments.
Dr Christine Ekechi, consultant obstetrician and gynaecologist at Imperial College Healthcare NHS Trust, drew on national maternity investigations to underline the importance of valid data, meaningful engagement with affected communities and rebuilding trust.
Menopause and midlife health were also identified as priorities for clinical research.
Professor Waljit Dhillo, consultant endocrinologist and professor of endocrinology and metabolism in Imperial’s Department of Metabolism, Digestion and Reproduction, described a new treatment for hot flushes, including for women unable to take hormone replacement therapy, such as those with a history of breast cancer.
The discussion then turned to bringing innovation into health systems. Innovators shared how data and technology are being used to close gaps in women’s health, while noting challenges in accessing funding to grow and scale.
Dr Helen O’Neill and Dr Deidre O’Neill, co-founders of Hertility Health, described predictive algorithms using self-reported data to help diagnose gynaecological conditions at scale.
Embedded into clinical workflows, the technology could reduce waiting times, identify conditions earlier and improve outcomes. They noted how “we have cures for the rarest genetic conditions but don’t even have the answers to common women’s health issues.”
Dr Lydia Mapstone, Dr Tara O’Driscoll and Dr Sioned Jones, co-founders of BoobyBiome, outlined work creating products that harness beneficial bacteria found in breast milk to support infant health.
By isolating and characterising key microbial strains, BoobyBiome has created synbiotics, combinations of beneficial bacteria and the food that nourishes them, to make these benefits accessible to all babies.
Speakers throughout the visit stressed the need to reduce variation in care quality and outcomes for women, strengthen prevention and education, and address power and equity in women’s health.
Professor the Lord Ara Darzi said: “It was a privilege to welcome Dr Biden and the Milken Institute to Imperial to meet some of the outstanding researchers, clinicians and innovators advancing women’s health.
“Imperial’s unique combination of clinical excellence and world-leading research positions us at the forefront of tackling the biggest health challenges facing society and the UK’s ambition for innovation demands nothing less.
“For too long, the health needs of women and girls across their life course have not received the attention they deserve.
“By working together across borders and disciplines, we can transform equitable access to care, accelerate the detection and treatment of disease, and ultimately improve health outcomes for millions of women in the UK and around the world.”
Fashion, beauty and lifestyle retailers have joined the American Heart Association to raise awareness of heart disease in women.
The Go Red. Shop with Heart. campaign launched at the New York Stock Exchange on 30 January.
Retailers will ask for donations at checkout in February or donate a percentage of proceeds from selected items.
More than four in 10 women in the US have some form of cardiovascular disease, a term for heart and blood vessel conditions such as heart disease and stroke.
Heart disease and stroke kill more women in the US each year than all forms of cancer combined.
Brands taking part include Away, Commando, Lafayette 148, Michael Kors, Reebok, ShopSimon.com, Summersalt, Torrid and White & Warren.
More than 40 other nationwide retailers are also inviting customers to support the organisation this February through its Life Is Why campaign.
Nancy Brown is chief executive officer of the American Heart Association.
She said: “Nearly 1 in 3 women die from cardiovascular disease each year, yet women are still profoundly under-represented in the clinical research, science and medicine that could save their lives.
“Retailers and consumers are uniquely positioned to turn everyday moments into meaningful change through Go Red. Shop with Heart.”
According to the American Heart Association 2026 Heart Disease and Stroke Statistics Update, heart disease is the leading cause of death in the US and stroke is the number four cause of death.
The organisation projects that at least six in 10 US adults will have cardiovascular disease within the next 30 years and related costs are expected to triple.
However, approximately 80 per cent of cardiovascular disease is preventable through lifestyle changes.
Mindy Grossman is a volunteer board member at the American Heart Association and partner and vice chair of Consello.
Grossman said: “Retail has always been a powerful connector.
“Shop with Heart gives our industry a shared platform to lead with purpose and unite consumers in support of heart health.”
Milken Institute has launched the Women’s Health Network digital platform with Velir x Brooklyn Data to speed collaboration and investment across research, care and technology.
The new website creates a hub for members to share content, connect and coordinate projects, with branding and the first public Drupal build delivered by Velir x Brooklyn Data. A launch video premiered on 4 November 2025 at the inaugural steering committee and member luncheon in Washington DC, then featured at the Milken Institute Future of Health Summit.
Phase two is scheduled for February 2026, adding member log-ins for networking and content exchange. Phase three in April 2026 will add advanced collaboration tools and expanded community features.
“This launch represents the type of mission-driven, cross-sector digital work we are incredibly proud to support,” said Eliza Pare, vice-president of client services at Velir. “The Women’s Health Network is poised to transform collaboration in women’s health, and we’re honoured to help build the digital infrastructure that will make that possible.”
Chaired by former first lady Dr Jill Biden, the Women’s Health Network brings together leaders from industry, startups, investors, health systems, patient groups, academia and philanthropy. More than 100 members have joined, with a steering group that includes organisations such as the American Cancer Society, American Heart Association, Amgen, Deloitte, GE Healthcare, Merck, Microsoft, Northwell Health, Organon and others.
Fertility1 week agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Fertility2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
News3 weeks agoSelf-employment linked to better cardiovascular health outcomes in Hispanic women
Pingback: London-based graduate develops device to help visually impaired women manage their periods - FemTech World